Role of epithelial sodium channel-related inflammation in human diseases

Front Immunol. 2023 Jul 25:14:1178410. doi: 10.3389/fimmu.2023.1178410. eCollection 2023.

Abstract

The epithelial sodium channel (ENaC) is a heterotrimer and is widely distributed throughout the kidneys, blood vessels, lungs, colons, and many other organs. The basic role of the ENaC is to mediate the entry of Na+ into cells; the ENaC also has an important regulatory function in blood pressure, airway surface liquid (ASL), and endothelial cell function. Aldosterone, serum/glucocorticoid kinase 1 (SGK1), shear stress, and posttranslational modifications can regulate the activity of the ENaC; some ion channels also interact with the ENaC. In recent years, it has been found that the ENaC can lead to immune cell activation, endothelial cell dysfunction, aggravated inflammation involved in high salt-induced hypertension, cystic fibrosis, pseudohypoaldosteronism (PHA), and tumors; some inflammatory cytokines have been reported to have a regulatory role on the ENaC. The ENaC hyperfunction mediates the increase of intracellular Na+, and the elevated exchange of Na+ with Ca2+ leads to an intracellular calcium overload, which is an important mechanism for ENaC-related inflammation. Some of the research on the ENaC is controversial or unclear; we therefore reviewed the progress of studies on the role of ENaC-related inflammation in human diseases and their mechanisms.

Keywords: cardiovascular stiffening; colitis; cystic fibrosis; epithelial sodium channel; hypertension; inflammation; tumor.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Epithelial Sodium Channels* / metabolism
  • Humans
  • Hypertension*
  • Inflammation
  • Signal Transduction
  • Sodium / metabolism

Substances

  • Epithelial Sodium Channels
  • Sodium

Grants and funding

This work was funded by the National Natural Science Foundations of China (82170648, 81971881, 82170670), Leading Talents of Zhongyuan Science and Technology Innovation (214200510027), Medical Science and Technology Program of Henan Province (SB201901045), and Funding for Scientific Research and Innovation Team of The First Affiliated Hospital of Zhengzhou University (ZYCXTD2023007).